UEMS Medical Specialty
Neurology & CNS
Research covering the central and peripheral nervous system, blood–brain barrier (BBB) permeability, neuroinflammation, neurodegenerative diseases, and brain-targeted nutraceutical delivery systems.
37
dossiers
Precision Microbiome & Gut-Brain Axis
Enteric-Targeted Butyrate Delivery for Vagal Nerve Stimulation: Addressing Gastric Degradation and Organoleptic Challenges
Designing oral butyrate formulations is challenged by premature gastric dissolution, proximal absorption, and severe organoleptic issues, preventing effective distal gut targeting and patient adherence.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Ketogenic Interventions in Neurodegeneration: Mechanisms, Clinical Efficacy, and Therapeutic Challenges
Developing clinically robust and compliant ketogenic interventions for neurodegenerative diseases requires overcoming challenges related to variable metabolic responses, sustained therapeutic ketosis, and precise delivery of ketone bodies or precursors in diverse patient populations.
Advanced BBB Permeability Solutions
Lipid Nanoformulations for CNS Delivery of Lipophilic Botanicals: BBB Transport & Catecholaminergic Nootropic Support
Delivering lipophilic botanicals to the central nervous system is hindered by the blood-brain barrier (BBB), rapid metabolism, and low solubility, leading to poor systemic and brain exposure for promising nootropic compounds.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Contemporary Sleep Disorder Management: ICSD-3-TR Diagnostic & Therapeutic Insights
Formulating effective, mechanism-directed therapeutics for the diverse and often comorbid sleep disorder endotypes is challenging due to complex pathophysiology, diagnostic delays, and the need for precision targeting based on individual biomarkers.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Food Supplements and Medical Foods in Brain Function: A Mechanism-Anchored Evidence Map
Formulators face significant challenges in developing evidence-based brain health supplements due to a lack of clear, mechanism-anchored frameworks for evaluating ingredient efficacy and quality of supporting human data across diverse brain function domains.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Borna Disease Virus 1: An Emerging Cause of Fatal Human Encephalitis
The critical challenge lies in developing effective, brain-penetrant antiviral agents and neuroprotective therapies for BoDV-1 encephalitis, compounded by diagnostic difficulties and a very narrow therapeutic window due to rapid progression and high fatality rates.
Intracellular Defense & IV-Alternatives
Bornaviruses: Genome Organization, Nuclear Replication, and Gene Expression Mechanisms
Developing effective antiviral therapies for nuclear-replicating RNA viruses like Bornaviruses requires deep understanding of their unique genomic organization and complex gene expression mechanisms, posing significant challenges for targeting viral replication without host toxicity.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Glioblastoma: Epidemiology, Pathology, Molecular Biology, and Therapeutic Landscape
Developing effective glioblastoma therapies is hampered by the tumor's aggressive proliferation, profound intratumoral heterogeneity, and the inherent difficulty in delivering therapeutic agents across the blood-brain barrier to the highly immunosuppressive microenvironment.
Precision Microbiome & Gut-Brain Axis
Norovirus: Virology, Epidemiology, Clinical Disease, Prevention, and Treatment Review
Developing effective norovirus vaccines and direct-acting antivirals is challenged by viral genetic diversity, genotype-specific host tropism, and the absence of a definitive cellular receptor. Current supportive care highlights an urgent need for targeted interventions.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Quantum Coherence in Photosynthetic Energy Transfer: Fenna-Matthews-Olson Complex Dynamics
Elucidating the precise quantum mechanical mechanisms governing energy transfer in biological systems poses a fundamental challenge for designing next-generation therapeutics that modulate cellular bioenergetics.
Precision Microbiome & Gut-Brain Axis
Rheumatoid Arthritis and Mental Health: Psychoneuroimmunological Links and Therapeutic Implications
The primary challenge is to develop targeted therapeutic and nutritional interventions that modulate inflammatory pathways and the HPA axis to improve mental health outcomes in patients suffering from chronic autoimmune conditions like rheumatoid arthritis.
Catecholamine Homeostasis & Executive Function
Psychological State and Cancer: Modulatory Roles in Progression and Outcomes
Developing targeted therapies that address the modulatory effects of chronic psychological stress and associated neuroendocrine pathways on tumor progression and patient outcomes in oncology remains a complex challenge.
Catecholamine Homeostasis & Executive Function
Undeclared Pharmacological Adulterants in Dietary Supplements: Regulatory Gaps and Anti-Doping Implications
CDMOs face the critical challenge of guaranteeing dietary supplements are free from undeclared pharmacological adulterants. This requires implementing robust analytical screening and stringent quality control amidst complex regulatory landscapes to prevent anti-doping rule violations and safeguard consumer health.
Catecholamine Homeostasis & Executive Function
ADHD and Autism Spectrum Disorder: Overlap, Distinctions, and Shared Genetic Influences
Developing targeted therapies for neurodevelopmental disorders like ADHD and ASD is challenging due to their significant clinical and genetic overlap, often leading to more severe comorbid presentations that complicate differential diagnosis and treatment efficacy.
Catecholamine Homeostasis & Executive Function
Clinical Advancements in Brain-Computer Interfaces: Speech, Motor, and Sensory Neuroprosthetics
Ensuring the long-term biocompatibility and stable performance of high-density neural interfaces within the dynamic CNS presents significant material science and biointegration challenges for sustained therapeutic device efficacy.
Catecholamine Homeostasis & Executive Function
Borderline Personality Disorder: Diagnostic Validity, Overlap, and Nosological Models
The intricate diagnostic landscape of Borderline Personality Disorder (BPD), marked by significant symptom overlap and debate on its construct validity, poses a critical challenge for developing precisely targeted pharmaceutical or nutraceutical interventions.
Catecholamine Homeostasis & Executive Function
Catecholamine Homeostasis and Executive Function: Optimizing Nutritional Product Formulations
Achieving stable and predictable cognitive benefits from dopaminergic nutritional products is challenging due to exposure variability ('spike-and-crash' kinetics) and the complex interplay of precursors, cofactors, and enzymatic bottlenecks in catecholamine biosynthesis.
Post-GLP-1 Metabolic Optimization
Drug-Induced Nutrient Depletion (DIND): Molecular Mechanisms of Iatrogenic Deficiencies in Chronic Pharmacotherapy
Mitigating drug-induced nutrient depletion requires advanced CDMO solutions to formulate targeted nutritional support that is compatible with existing chronic pharmacotherapy and addresses diverse mechanistic pathways of depletion.
Precision Microbiome & Gut-Brain Axis
Hidden Pharmacodynamics of Pharmaceutical Formulations: Excipient, Impurity, and Oxidation Index Impact on Clinical Safety
Pharmaceutical and nutraceutical formulations often overlook the direct pharmacodynamic effects of excipients and the toxicity of oxidation byproducts, risking unforeseen clinical safety issues that extend beyond the API's profile.
Precision Microbiome & Gut-Brain Axis
Gut-Brain Axis and Mental Illness: Microbiota, Mechanisms, and Testable Hypotheses
Translating complex gut-brain axis insights into effective, targeted formulations for psychiatric conditions requires addressing variable microbiome signatures, diverse mechanistic pathways, and inconsistent clinical trial outcomes.
Cellular Longevity & Senolytics
Immunometabolism, Active Resolution of Inflammation, and Specialized Pro-resolving Mediators (SPMs) from EPA/DHA
Current anti-inflammatory strategies often inhibit active resolution pathways, leading to chronic inflammation. Developing stable, bioavailable specialized pro-resolving mediators (SPMs) or modulators that enhance endogenous SPM biosynthesis without compromising resolution is a significant challenge.
Catecholamine Homeostasis & Executive Function
Kava (Piper methysticum) in Psychiatry: Clinical Effects, Mechanisms, and Safety Signals with Emphasis on Anxiety Disorders
Developing safe and effective Kava-derived anxiolytics is challenging due to inherent hepatotoxicity concerns and potential herb-drug interactions, necessitating novel formulation strategies to mitigate adverse events while preserving therapeutic efficacy.
Catecholamine Homeostasis & Executive Function
Narcissistic Parenting and ADHD: Indirect Pathways and Diagnostic Implications
Precisely differentiating ADHD from trauma-related phenocopies in children of narcissistic parents presents a significant diagnostic hurdle, complicating targeted therapeutic development.
Precision Microbiome & Gut-Brain Axis
The Neuroimmune Continuum: Mechanisms, Paradigm Shifts, and Translational Frontiers in Psychoneuroimmunology
Translating complex psychoneuroimmunological mechanisms, including BBB permeability, specific cytokine pathways, and targeted microglial modulation, into stable and bioavailable therapeutic formulations presents a significant CDMO hurdle.
No dossiers match the selected MeSH topic in this page. Try another tag or clear the filter.
Custom Formulation Available
Need a Dossier Built Around Your Molecule?
Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.